Dual GIP/GLP-1 agonist achieving up to 22.5% weight reduction in trials — FDA-approved as Mounjaro (diabetes) and Zepbound (weight management).
10mg, 20mg, 30mg, 40mg
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Your cart is currently empty!
Notifications
Reviews
There are no reviews yet.